Researchers
Discover all researchers in life sciences
Discover all researchers in life sciences
Faculty Research Scholar at Medicine
Ask questions about Muhammad Wahab Amjad's research, publications, and ongoing work
Developed folate-conjugated cholic acid-polyethylenimine micelles for the co-delivery of doxorubicin and siRNA to colorectal adenocarcinomas, demonstrating in vivo antitumor activity.
Synthesized and evaluated α,β-unsaturated carbonyl-based compounds and their oxime analogs as potential anticancer agents to overcome multidrug resistance in tumor cells.
Investigated the development of curcumin analogs to improve antioxidant, anti-inflammatory, and antimicrobial efficacy, reviewing new trends and future perspectives.
Reviewed recent advances in the design, development, and targeting mechanisms of polymeric micelles for siRNA delivery in cancer therapy.
Synthesized and evaluated new tetramethylpyrazine-based chalcone derivatives as potential anti-Alzheimer agents, contributing to the development of treatments for neurodegenerative diseases.
Investigated the use of nanoparticles incorporated into hydrogels for the delivery of antimicrobial agents, highlighting developments and trends in this area.
Dr. Muhammad Wahab Amjad is a Faculty Research Scholar at the University of Pittsburgh, specializing in advanced drug delivery systems and the development of novel therapeutic strategies. His research focuses on innovative approaches to improve drug efficacy, particularly in cancer and neurological disorders, with a strong emphasis on nanomedicine and targeted therapies.
Researchers with overlapping expertise and complementary work
Finding similar researchers...